| Description | Symbol | Type | #Stocks | Cap (M) | 1Day %* | 1Wk %* | 1Mo %* | 3Mo %* | 6Mo %* | 1Yr %* |
|---|---|---|---|---|---|---|---|---|---|---|
| North America (Primary) | PRIMARYNOAM | Univ | 7,888 | 76,952,114 | -0.20% | 2.41% | 2.46% | 8.62% | 22.14% | 15.45% |
| Healthcare | HEALTHCARE | Sector | 1,239 | 6,793,639 | -0.92% | -0.80% | 3.87% | 9.80% | 10.41% | 0.30% |
| Biopharmaceuticals | BIOPHARMA | SubSec | 620 | 3,420,492 | -0.58% | -0.26% | 3.78% | 9.36% | 16.87% | 6.86% |
| Other Biopharmaceuticals | BIOPHARMAOTHER | Industry | 111 | 1,266,773 | -0.60% | -1.93% | 0.01% | 9.28% | 19.21% | 11.60% |
| Toxicology Biopharmaceuticals | TOXICOLOGY | SubInd | 7 | 1,251 | -1.93% | -4.76% | 23.53% | 67.11% | 129.17% | 14.03% |
| Description | Symbol | Type | #Stocks | Cap (M) | 1Day %* | 1Wk %* | 1Mo %* | 3Mo %* | 6Mo %* | 1Yr %* |
|---|---|---|---|---|---|---|---|---|---|---|
| Toxicology Biopharmaceuticals | TOXICOLOGY | SubInd | 7 | 1,251 | -1.93% | -4.76% | 23.53% | 67.11% | 129.17% | 14.03% |
| Aquestive Therapeutics, Inc. | AQST:USAAQST:USA | Stock | 1 | 644 | -3.57% | -5.26% | 15.92% | 69.63% | 116.00% | 18.03% |
| S&P 500 | SPY:USASPY:USA | Benchmark | 14,199 | 97,508,869 | 0.05% | 2.93% | 3.18% | 10.87% | 23.79% | 19.78% |
* Colors indicate performance relative to the benchmark.